A digital health company has raised $25 million in Series B financing, according to its press release.

Analytics 4 Life raised the money by investors, including physicians, health care professionals and medical device experts.

The company, headquartered in the Research Triangle Park, creates technology to assess the presence of coronary artery disease.

The cardiac imaging device is currently under clinical investigation.

Analytics 4 Life uses artificial intelligence to produce novel diagnostic images to scan signals naturally emitted from the body that is radiation-free and exercise-free.

Current CAD methods are both risky and costly for the patient.

By using artificial intelligence, Analytics 4 Life has led the right patients to the right personalized treatments in a faster and safer manner.

Crawford previously led and founded Sapheon Inc., a cardiovascular-focused medical device company, from inception to its $238 million acquisition.

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.